News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC – Top Science
May 19, 2024, 05:07

First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC – Top Science

Top Science shared on X:

“This is the first prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced Non- Small Cell Lung Cancer (NSCLC).

Sintilimab was efficacious and well-tolerated irrespective of PD-L1 expression level in patients with advanced NSCLC and had similar efficacy and safety to Pembrolizumab.”

First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC - Top Science First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC - Top Science

Additional information.
Source: Top Science/X

 

anti-PD-1 antibodies Bin Gan Bin-Chao Wang cancer Chong-Rui Xu E-E Ke Hai-Yan Tu Hong-Hong Yan Hua-Jun Chen Jia-Xin Lin Jia-Yi Deng Jie Huang Jin-Ji Yang Ming-Yi Yang Ming-Ying Zheng NSCLC OncoDaily Oncology pembrolizumab Qing Zhou Si-Yang Maggie Liu Sintilimab Top Science Wen-Zhao Zhong Xu-Chao Zhang Yang-Si Li Yangqiu Li Yi-Long Wu Zhen Wang
Special Coverage
Blog
Apr 1, 2025, 19:09
Sally Susman: Thank you for joining me for Memoir March
Blog
Apr 1, 2025, 19:03
Megan-Claire J. Chase: Amazing team from Pink Warrior Angels at the exhibitor table right next to mine
Blog
Apr 1, 2025, 19:03
AIQ Solutions Tackles the Complex Reality of Unequal Metastatic Cancer Treatment Responses - CancerX
Blog
Apr 1, 2025, 18:58
Kevin Jackson Announces New Role as Lead Events Manager at UF Health Cancer Center
Blog
Apr 1, 2025, 18:48
Understanding Abnormal Coagulation at EPHOC 2025 - MENA Conference
Blog
Apr 1, 2025, 18:43
Debra Montague Joins Medscape Faculty Steering Committee as Patient Representative
Blog
Apr 1, 2025, 18:37
Binay Shah: Three Timely Levers to help bridge growing gap in Cancer Care
Insight
Apr 1, 2025, 18:33
Fumiko Ladd Chino: Over 1,200 scientists may leave the US due to disruptions from the Trump administration
Blog
Apr 1, 2025, 18:29
How EveryGrant is Helping Grantmakers Make a Global Impact - Conquer Cancer, the ASCO Foundation
Blog
Apr 1, 2025, 18:28
How tobacco smoking contributes to development of cancers of the head and neck - IARC/WHO
Blog
Apr 1, 2025, 18:26
Benjamin Perrotta: St. Baldricks was a success
Blog
Apr 1, 2025, 18:22
Last days to submit your abstract and topic proposal for SIOP 2025